Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Aug 28, 2024
- Accession no.
- 0001415889-24-022447
- Filed
- Aug 28, 2024
- Trade date
- Aug 26, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $93.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +269 | $129.49 | +$34,832.81 | 399 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −28 | $347.27F2 | −$9,723.56 | 371 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −196 | $348.20F3 | −$68,247.2 | 175 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −22 | $349.21 | −$7,682.62 | 153 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −23 | $350.86 | −$8,069.78 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −269 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $349.78 to $347.715. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $347.86 to $348.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.